News Release

Mallinckrodt plc to Report First Quarter Results on Thursday, February 6, 2014

DUBLIN--(BUSINESS WIRE)--Jan. 7, 2014-- Mallinckrodt plc (NYSE: MNK) will report fiscal first quarter 2014 results on February 6, 2014. The company will hold a conference call for investors beginning at 8:30am U.S. Eastern Time. The call can be accessed in three ways.

  • At the Mallinckrodt website:
  • By telephone: For both “listen-only” participants and those who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-318-8614. For participants outside the U.S., the dial-in number is 617-399-5133. The access code for all callers is 81312057.
  • Through an audio replay: A replay of the call will be available beginning at 12:30pm U.S. Eastern Time on February 6, 2014, and ending at 11:59pm U.S. Eastern Time on February 13, 2014. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617- 801-6888. The replay access code for all callers is 83253336.


Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 70 countries. The company’s fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit

Source: Mallinckrodt

John Moten, 314-654-6650
Vice President, Investor Relations
Lynn Phillips, 314-654-3263
Manager, Media Relations
Meredith Fischer, 314-654-3318
Senior Vice President, Communications